𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic use of benzodiazepines and psychomotor and cognitive test performance

✍ Scribed by Irwin Lucki; Karl Rickels; Andrew M. Geller


Publisher
Springer
Year
1986
Tongue
English
Weight
1022 KB
Volume
88
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis


The performance of 43 long-term users (average = 5 years) of benzodiazepine (BZ) medications was examined on a battery of behavioral tasks, cognitive tests, and subjective mood rating scales. The performance of the chronic BZ users did not differ significantly from age-and sexmatched anxious subjects, except that critical flicker fusion (CFF) thresholds were lower and subjective ratings of tranquilization were higher in the BZ users. Twenty-two subjects were reexamined in order to determine the acute effects of BZ medications in long-term users. The acute administration of BZ medications significantly increased CFF thresholds, improved digit-symbol substitution test performance, impaired the delayed recall of verbal material, increased subjective ratings of tranquilization, and reduced physical sedation. Motor performance tests were not impaired and subjective feelings of sedation were not increased after the acute administration of BZs by chronic users. During withdrawal from long-term BZ use (17 subjects), CFF thresholds were elevated, subjective ratings of physical sedation and anxiety were increased, but performance on other psychomotor and cognitive tests was not altered. The results suggest that tolerance develops selectively to different behavioral and subjective effects of BZ medications with their continued use. Tolerance failed to develop to the antianxiety effects, the reduction of CFF threshold, and to the impairment of short-term memory caused by BZs. However, chronic users of BZ medications failed to demonstrate psychomotor-impairing or sedating effects to BZ medications. The results have implications for evaluating the safety of the long-term use of BZ medications.


πŸ“œ SIMILAR VOLUMES


Benzodiazepine-induced reduction in acti
✍ Jean Dawson; Julia Boyle; Neil Stanley; Sigurd Johnsen; Ian Hindmarch; Debra J. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

## Abstract ## Objective To assess whether actigraphy is sensitive to benzodiazepine‐induced changes in cognitive and psychomotor performance and sleep. ## Methods Healthy young volunteers (__n__ = 23; 11 males), were randomised to a double‐blind, placebo‐controlled, crossover trial. Actigraphy

Objective and subjective assessments of
✍ Mauri J. Mattila; Marja Mattila; Kari Aranko πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 757 KB

The aim of this double-blind crossover trial was to compare the objective and subjective effects of flupentixol and lorazepam on human performance, and to reveal possible interactions between flupentixol and diazepam. Twelve healthy students received at 1-week intervals oral single doses of flupenti

Use of benzodiazepines, depressive sympt
✍ Peter van Vliet; Roos C. van der Mast; Marianne van den Broek; Rudi G. J. Westen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

## Abstract ## Objective Benzodiazepine use is more frequently observed in depressive and cognitively impaired subjects. The temporal relation behind this association is unknown. Here, we studied whether benzodiazepine use is associated with depressive symptoms and cognitive function and what the

Psychomotor performance of psychiatric i
✍ A. K. Agarwal; R. Kalra; M. V. Natu; A. P. Dadhich; R. S. Deswal πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 41 KB

Fifty psychiatric inpatients included in the study were diagnosed as having substance related disorder, schozophrenia, bipolar disorder, depressive disorder or anxiety disorder based on DSM-IV and ICD-10. All the patients were on multiple drug therapy for a minimum of 7 days in the hospital. The psy